Skip to main content
SpringerLink
Log in

Sertraline cost effective for depressive symptoms

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2017/2018 British pounds

  2. general practitioners

  3. EuroQol 5-dimension 3-level instrument

Reference

  • Hollingworth W, et al. Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT. PharmacoEconomics-Open : 27 Nov 2019. Available from: URL: https://doi.org/10.1007/s41669-019-00188-5

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sertraline cost effective for depressive symptoms. PharmacoEcon Outcomes News 843, 31 (2019). https://doi.org/10.1007/s40274-019-6458-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6458-5

Search

Navigation